Literature DB >> 10871045

CCAAT/enhancer binding protein beta mediates the activation of the murine alpha1(I) collagen promoter by acetaldehyde.

F A Attard1, L Wang, J J Potter, L Rennie-Tankersley, E Mezey.   

Abstract

Acetaldehyde was previously shown to activate the alpha1(I) and alpha2(I) collagen promoters and to increase collagen production in activated stellate cells. Also, CCAAT/enhancer binding protein beta (C/EBPbeta) binds and activates the mouse alpha1(I) collagen promoter. This study investigates the role of C/EBPbeta in mediating the activation of the alpha1(I) collagen promoter by acetaldehyde. Nuclear extracts isolated from cultured activated rat hepatic stellate cells formed four protein-DNA complexes on electrophoretic mobility shift assay with an oligonucleotide including the C/EBP binding site between -365 and -335 in the alpha1(I) collagen promoter. The four complexes were identified to represent C/EBPbeta binding to the oligonucleotide by supershift with C/EBPbeta antibody. The principal C/EBP isoform found in the nuclear extracts from stellate cells was C/EBPbeta, with very low amounts of C/EBPalpha detected. Acetaldehyde (200 microM) increased C/EBPbeta protein in stellate nuclear extracts, increased its binding to the promoter, and activated the alpha1(I) collagen promoter in transfected stellate cells. Mutation of the C/EBPbeta binding site markedly decreased nuclear protein binding. A transfected promoter, mutated at the C/EBP binding site, had decreased basal activity, was not activated by acetaldehyde, and was not activated when cotransfected with a C/EBPbeta expression vector. This study shows that C/EBPbeta is the predominant C/EBP isoform found in activated stellate cells and that increased C/EBPbeta protein and C/EBPbeta binding to a proximal C/EBP binding site in the promoter mediates the activating effect of acetaldehyde.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10871045     DOI: 10.1006/abbi.2000.1803

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  7 in total

1.  Transforming growth factor β (TGFβ) cross-talk with the unfolded protein response is critical for hepatic stellate cell activation.

Authors:  Zhikui Liu; Chao Li; Ningling Kang; Harmeet Malhi; Vijay H Shah; Jessica L Maiers
Journal:  J Biol Chem       Date:  2019-01-04       Impact factor: 5.157

Review 2.  Role of ethanol in the regulation of hepatic stellate cell function.

Authors:  Jian-Hua Wang; Robert-G Batey; Jacob George
Journal:  World J Gastroenterol       Date:  2006-11-21       Impact factor: 5.742

Review 3.  Pathogenesis of alcoholic liver disease: role of oxidative metabolism.

Authors:  Elisabetta Ceni; Tommaso Mello; Andrea Galli
Journal:  World J Gastroenterol       Date:  2014-12-21       Impact factor: 5.742

4.  Early response of alpha2(I) collagen to acetaldehyde in human hepatic stellate cells is TGF-beta independent.

Authors:  Gianluca Svegliati-Baroni; Yutaka Inagaki; Ana-Rosa Rincon-Sanchez; Cindy Else; Stefania Saccomanno; Antonio Benedetti; Francesco Ramirez; Marcos Rojkind
Journal:  Hepatology       Date:  2005-08       Impact factor: 17.425

5.  Effects of CD14 macrophages and proinflammatory cytokines on chondrogenesis in osteoarthritic synovium-derived stem cells.

Authors:  Sun Ae Han; Sahnghoon Lee; Sang Cheol Seong; Myung Chul Lee
Journal:  Tissue Eng Part A       Date:  2014-07-22       Impact factor: 3.845

6.  De novo production of K-alpha1 tubulin-specific antibodies: role in chronic lung allograft rejection.

Authors:  Trudie A Goers; Sabarinathan Ramachandran; Aviva Aloush; Elbert Trulock; G Alexander Patterson; Thalachallour Mohanakumar
Journal:  J Immunol       Date:  2008-04-01       Impact factor: 5.422

Review 7.  Liver fibrosis and hepatic stellate cells: Etiology, pathological hallmarks and therapeutic targets.

Authors:  Chong-Yang Zhang; Wei-Gang Yuan; Pei He; Jia-Hui Lei; Chun-Xu Wang
Journal:  World J Gastroenterol       Date:  2016-12-28       Impact factor: 5.742

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.